How ocular telehealth can create new revenue opportunities in primary care
As we head into 2021, primary care continues to be at the front lines of the pandemic, which is far from over. A recent survey of 1,472 clinicians, conducted by the Larry Green Center in partnership with the Primary Care Collaborative, shows:
- 25% report fee-for-service volume is down, yet 20% still waived copays and reduced fees1
- Despite inadequate reimbursement, 65% used telehealth for patients with chronic conditions1
One respondent from Pennsylvania commented, “Patients are becoming sicker during the pandemic. I’m seeing more uncontrolled diabetics and new diabetics. I am concerned about patients’ isolation and mental health. People are delaying care.1 In addition, the financial fallout of the pandemic means more mergers and other hits to independent practices.1
PCP’s will continue to feel the fallout of COVID-19 through 2021. In a climate of falling revenues, primary care physicians still need to treat their patients. Closing care gaps remain a priority. According to the CDC, 6 in 10 Americans have a chronic disease, 4 in 10 have two or more, and 1 in 10 have diabetes.3 HEDIS measurements have not changed, and point-of-care testing for your diabetic patients can help you close these quality measures with a positive effect on your revenues and improved patient care.
Unlike other companies, Topcon enables you to implement point-of-care testing for diabetes eye exams and takes the economic uncertainty out of doing what is best for your patients and practice.
- No up-front capital costs
- Reimbursement support
- Workflow integration
For more details or a live conversation with one of our Topcon team members call 551-231-7412.
Disclaimer: Consumer Advertising. No aspect of this advertisement has been approved by the American Medical Association, National Committee for Quality Assurance, or the Centers for Medicare & Medicaid Services.